Akorn Inc (AKRX) 34.45 $AKRX
Uptrend Call Working As Akorn Stock Rises 41.5% (AKRX)
Comtex SmarTrend(R) - Thu Jul 24, 4:41PM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 41.47% as of today's recent price of $34.73.
Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:46AM CDT
Acasti Pharma (ACST) was a big mover last session, with shares rising over 7% on the day.
Uptrend Call Working As Akorn Stock Rises 35.7% (AKRX)
Comtex SmarTrend(R) - Thu Jul 17, 11:02AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 35.72% as of today's recent price of $33.32.
Market Losses Its Swagger In Afternoon Trade
at Investor's Business Daily - Wed Jul 16, 3:26PM CDT
Wednesday's stock market opened with a swagger, but closed with a stagger as it gave up a good chunk of a morning bounce. The Nasdaq rose 0.2%; the S&P 500 and the Dow Jones industrial average gained 0.4%. Volume was higher on the Nasdaq and lower on...
Stocks Recover From Early Fade; Whiting Hits New High
at Investor's Business Daily - Wed Jul 16, 12:35PM CDT
Stocks were again off their session highs but have regained some momentum. The Nasdaq, S&P 500 and Dow Jones industrial average were each up 0.4%. Earlier, the Nasdaq and S&P 500 retraced most of their morning gains. Turnover was again tracking mixed...
Adamas Pharmaceuticals, Inc. (ADMS) in Focus: Stock Rises 7.04% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 16, 7:44AM CDT
Adamas Pharmaceuticals, Inc. (ADMS) was a big mover last session, as the company saw its shares rise 7% on the day.
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information
GlobeNewswire - Wed Jul 16, 3:52AM CDT
Akorn, Inc. (Nasdaq:AKRX) will host a conference call on Tuesday, August 5, 2014, to discuss second quarter 2014 results followed by a Q&A session. The company will release earnings the same day before the market opens.
Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 15, 7:44AM CDT
Progenics Pharmaceuticals, Inc. (PGNX) was a big mover last session, as the company saw its shares rise over 8% on the day.
Stocks Recover Impressively; Gap Slumps In After Hours
at Investor's Business Daily - Thu Jul 10, 4:22PM CDT
Major averages ended with modest losses Thursday, recovering impressively after an early sell-off. Wall Street was rattled early over newfound concerns about the health of European banks after Espirito Santo International, the parent company of...
Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 3:43PM CDT
Supernus Pharmaceuticals, Inc.'s (SUPN) inked a non-dilutive royalty deal worth $30 million with HealthCare Royalty Partners.
Stocks Claw Way Back After Morning Sell-Off
at Investor's Business Daily - Thu Jul 10, 12:42PM CDT
Stocks continued to claw their way back from opening losses Thursday, with the indexes coming more than halfway back in early-afternoon trading. The Nasdaq and S&P 500 fell less than 0.4% and the Dow Jones industrial average was off 0.5%. Volume was...
Shares of AKRX Up 32.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 10, 9:41AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 32.59% as of today's recent price of $32.55.
Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 8:21AM CDT
Acasti Pharma Inc. (ACST) was a big mover last session, as the company saw its shares rise by roughly 8% on the day.
Walgreens Sees Robust Growth in June Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 08, 5:20PM CDT
Walgreens (WAG) opened 39 new drug stores in the third-quarter of fiscal 2014 in an attempt to optimize its store footprint.
Teva's Contraceptive Gets Positive CHMP Opinion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 5:00PM CDT
Teva Pharmaceutical Industries Ltd.'s (TEVA) extended-regimen oral contraceptive, Seasonique got a positive recommendation from theCommittee for Medicinal Products for Human Use.
Stocks Add To Losses; TAL Education Bucks Weakness
at Investor's Business Daily - Mon Jul 07, 12:41PM CDT
Stocks worsened a little more Monday afternoon, with techs taking the hardest hit. The Nasdaq stretched its loss to 0.7%. Solar, software and biotechs were among the day's worst-performing groups. The S&P 500 and the Dow Jones industrial average lost...
Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week
at Investor's Business Daily - Thu Jul 03, 5:26PM CDT
It was a healthy week for leaders, with more than 20% of the IBD 50 list of top-rated growth stocks pressing to new highs. Three of those staged breakouts, and nearly two-in-five on the list continued intently working on base patterns. Drugmakers...
Akorn Shares Up 40.0% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Thu Jul 03, 9:13AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 2 months, Akorn has returned 39.98% as of today's recent price of $34.37.
Edwards Lifesciences Monitor Gets FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 2:00PM CDT
Edwards Lifesciences' (EW) ClearSight system is the most advanced non-invasive hemodynamic monitor that amplifies a physician's access to a patient's advanced hemodynamic parameters.
Uptrend Call Working As Akorn Stock Rises 41.5% (AKRX)
Comtex SmarTrend(R) - Thu Jul 24, 4:41PM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 41.47% as of today's recent price of $34.73.
Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:46AM CDT
Acasti Pharma (ACST) was a big mover last session, with shares rising over 7% on the day.
Uptrend Call Working As Akorn Stock Rises 35.7% (AKRX)
Comtex SmarTrend(R) - Thu Jul 17, 11:02AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 35.72% as of today's recent price of $33.32.
Market Losses Its Swagger In Afternoon Trade
at Investor's Business Daily - Wed Jul 16, 3:26PM CDT
Wednesday's stock market opened with a swagger, but closed with a stagger as it gave up a good chunk of a morning bounce. The Nasdaq rose 0.2%; the S&P 500 and the Dow Jones industrial average gained 0.4%. Volume was higher on the Nasdaq and lower on...
Stocks Recover From Early Fade; Whiting Hits New High
at Investor's Business Daily - Wed Jul 16, 12:35PM CDT
Stocks were again off their session highs but have regained some momentum. The Nasdaq, S&P 500 and Dow Jones industrial average were each up 0.4%. Earlier, the Nasdaq and S&P 500 retraced most of their morning gains. Turnover was again tracking mixed...
Adamas Pharmaceuticals, Inc. (ADMS) in Focus: Stock Rises 7.04% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 16, 7:44AM CDT
Adamas Pharmaceuticals, Inc. (ADMS) was a big mover last session, as the company saw its shares rise 7% on the day.
Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information
GlobeNewswire - Wed Jul 16, 3:52AM CDT
Akorn, Inc. (Nasdaq:AKRX) will host a conference call on Tuesday, August 5, 2014, to discuss second quarter 2014 results followed by a Q&A session. The company will release earnings the same day before the market opens.
Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 15, 7:44AM CDT
Progenics Pharmaceuticals, Inc. (PGNX) was a big mover last session, as the company saw its shares rise over 8% on the day.
Stocks Recover Impressively; Gap Slumps In After Hours
at Investor's Business Daily - Thu Jul 10, 4:22PM CDT
Major averages ended with modest losses Thursday, recovering impressively after an early sell-off. Wall Street was rattled early over newfound concerns about the health of European banks after Espirito Santo International, the parent company of...
Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 3:43PM CDT
Supernus Pharmaceuticals, Inc.'s (SUPN) inked a non-dilutive royalty deal worth $30 million with HealthCare Royalty Partners.
Stocks Claw Way Back After Morning Sell-Off
at Investor's Business Daily - Thu Jul 10, 12:42PM CDT
Stocks continued to claw their way back from opening losses Thursday, with the indexes coming more than halfway back in early-afternoon trading. The Nasdaq and S&P 500 fell less than 0.4% and the Dow Jones industrial average was off 0.5%. Volume was...
Shares of AKRX Up 32.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 10, 9:41AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 32.59% as of today's recent price of $32.55.
Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 8:21AM CDT
Acasti Pharma Inc. (ACST) was a big mover last session, as the company saw its shares rise by roughly 8% on the day.
Walgreens Sees Robust Growth in June Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 08, 5:20PM CDT
Walgreens (WAG) opened 39 new drug stores in the third-quarter of fiscal 2014 in an attempt to optimize its store footprint.
Teva's Contraceptive Gets Positive CHMP Opinion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 5:00PM CDT
Teva Pharmaceutical Industries Ltd.'s (TEVA) extended-regimen oral contraceptive, Seasonique got a positive recommendation from theCommittee for Medicinal Products for Human Use.
Stocks Add To Losses; TAL Education Bucks Weakness
at Investor's Business Daily - Mon Jul 07, 12:41PM CDT
Stocks worsened a little more Monday afternoon, with techs taking the hardest hit. The Nasdaq stretched its loss to 0.7%. Solar, software and biotechs were among the day's worst-performing groups. The S&P 500 and the Dow Jones industrial average lost...
Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week
at Investor's Business Daily - Thu Jul 03, 5:26PM CDT
It was a healthy week for leaders, with more than 20% of the IBD 50 list of top-rated growth stocks pressing to new highs. Three of those staged breakouts, and nearly two-in-five on the list continued intently working on base patterns. Drugmakers...
Akorn Shares Up 40.0% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Thu Jul 03, 9:13AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 2 months, Akorn has returned 39.98% as of today's recent price of $34.37.
Edwards Lifesciences Monitor Gets FDA Nod - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 2:00PM CDT
Edwards Lifesciences' (EW) ClearSight system is the most advanced non-invasive hemodynamic monitor that amplifies a physician's access to a patient's advanced hemodynamic parameters.
